Since we discussed the role of ROS-driven Nrf2 and NF-κB activation in human melanoma and their dual function as pro- and anti-oncogenic molecules, we believe that it is appropriate to better dissect the interplay between them. The gene discussed is NFE2L2; the disease is melanoma.